RC288
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RC288, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors [Phase 1, Phase 2]